Skip to main content
OpenTrials
Completed

NCT Number: NCT03175614

Effectiveness to Weight Loss in Sedentary and Overweight People Using a Smartphone Application.

This is a randomized clinical trial aimed at obese and sedentary subjects aged 20 to 65 years selected in urban primary care centers of 5 centers (Spain). Its objective is to evaluate the effects of the addition of an ICT tool developed for the Smartphone application and a Smartband in support of behavioral and educational recommendations to reduce weight.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Primary Care Research Unit - The Alamedilla Center for Health

Salamanca, 37006, Spain

About this study

  • Objetive: To develop and validate an application for the use in Smartphone in which the management of a SmartBand is included and evaluate the effect of adding this tool of information and communication technology (ICT), to a standardized intervention reduce weight, reduce sedestation time, increase physical activity and decrease total caloric intake in obese and sedentary subjects.
  • Design and setting: A clinical of two parallel group, multicenter, randomized, aimed at assessing the effects of adding an ICT tool (intervention) to support behavioral and educational recommendations (control) in physical activity and weigh loss. Population: 700 obese and sedentary subjects will be included, 20 to 65 aged, selected by random sampling in 5 centers.
  • Measurements and intervention: physical and sedeentary acivity will be assessed with an accelometer and IPAQ and Marshall Questionnaires, the nutrition by a food frequency and adherence to the Mediterranean diet survey and weight loss with body mass index and waist circumference. Vascular function with a wrist-worn tonometer (blood pressure, augmentation index and pulse rate) will be evaluated and also the Cardio Ankle Vascular Index and carotid intima media thickness. The advice on nutrition (plate method) and exercise will be common to both groups. The intervention group will be added a training for 3 months in use of ICT tool described, designed to foment a healthy and low-calorie diet and increased physical acivity and decreased sedentary.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Obese subjects (IMC ≥ 27.5 to <40), classified as sedentary according to the short physical activity questionnaire validated in the EVIDENT II study.

Exclusion criteria

  • Older than 65 years are excluded, due to difficulties in the use of ICTs.
  • Advanced respiratory, renal or liver disease.
  • Several mental illness
  • Coronary or cerebrovascular atherosclerotic disease, grade II or higher NYHA heart failure.
  • Moderate or severe COPD
  • Muscular-skeletal pathology that inhibit mobility
  • Subjects who can not exercise or follow a hypocaloric diet.
  • Oncologic disease in treatment diagnosed in the last 5 years.
  • Terminal situation
  • Pregnancy
  • Bariatric surgery
  • Those with any other circumstance that the investigators consider could interfere with the study procedures

Treatment and study plan

Intervention group

Other

Smartphone with APP (EVIDENT III) and a Smartband for 3 months. Counseling on physical activity and nutrition

Control: Lifestyle counseling

Other

Conseling on physical activity and nutrition (intervention)

Primary outcomes

  1. Weight reduction

    Time frame: 1 year

    Measurement by kilograms

Secondary outcomes

  1. Increase steps/day

    Time frame: 1 year

    Steps/day by accelerometer

  2. Decrease sedestation minute week

    Time frame: 1 year

    Minutes week in sedentary activity by Activpal monitor

  3. Decrease total caloric intake/day

    Time frame: 1 year

    Calories/day by Food frecuency questionnaire

  4. Improve Quality of life

    Time frame: 1 year

    Measurement by IWQOL-L

  5. Augmentation index

    Time frame: 1 year

    Central and peripheral augmentation index

  6. Adiponectin

    Time frame: 1 year

    Inflammation marker

Sponsors and collaborators

Lead sponsor

Instituto de Investigación Biomédica de Salamanca

Other

Collaborators

  • Instituto de Salud Carlos III

Registry information

Official study title

EVIDENT3 Study: A Randomized, Controlled Clinical Trial to Reduce Inactivity and Caloric Intake in Sedentary, Overweight People Using a Smartphone Application. Study Protocol.

Acronym: EVIDENT3

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jun 5, 2017
Registry last updated
May 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.